Serono has announced it has reached a major milestone towards identifying the genes involved in multiple sclerosis.The company has identified …
The share prices of Roche and Genentech have risen sharply on the back of news that Avastin extends the life …
Bristol-Myers Squibb's Baraclude (entecavir) has been recommended for first-line treatment of chronic hepatitis B despite potential cancer risks.The US Food …
US dermatologists have voiced their disapproval of new FDA restrictions on two eczema drugs because of potential cancer risks.The US …
Pfizer has entered into a collaboration with the UK's Medical Research Council commercial arm to develop new drug discovery techniques.Medical …
The hi-tech vision of doctors communicating with their patients via video, digital imaging and electronic data transmission is as far …
Practice based commissioning, the latest radical reform which will re-shape the way the NHS treats patients is just days away …
England's primary care trusts are under growing pressure to merge, and their numbers could be reduced by a third within …
The global pharmaceutical industry achieved annual sales of over $500 billion for the first time ever in 2004, up 7% …
Bristol-Myers Squibb and Otsuka Pharmaceuticals have renewed Pope Woodhead's contract to provide PR support for Abilify, their antipsychotic treatment for …
A 61-year-old man from Kent has become one of the first ever patients to be cured of type I diabetes …
New data shows AstraZeneca's blockbuster drug Seroquel to be effective in reducing agitation in elderly patients with Alzheimer's disease (AD).Seroquel …
Nurses could soon be able to independently prescribe for long-term conditions such as asthma and diabetes, under proposals being considered …
UK regulator the MHRA has reiterated its guidance on SSRI antidepressants and stressed their safety after a new article linked …
A row over a pensioner's repeatedly cancelled shoulder operation has escalated into a key election battle on the state of …
The NHS Alliance has warned that the planned replacement to the controversial star ratings performance indicators may lead to 'perverse …